Search Page

1

Cite

Share

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.

Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK. Revicki DA, et al. Among authors: willian mk. Health Qual Life Outcomes. 2008 Oct 2;6:75. doi: 10.1186/1477-7525-6-75. Health Qual Life Outcomes. 2008. PMID: 18831744 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.

Bansback N, Sizto S, Sun H, Feldman S, Willian MK, Anis A. Bansback N, et al. Among authors: willian mk. Dermatology. 2009;219(3):209-18. doi: 10.1159/000233234. Epub 2009 Aug 5. Dermatology. 2009. PMID: 19657180 Review.

Cite

Share

3

Cite

Share

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.

Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA. Shikiar R, et al. Among authors: willian mk. Health Qual Life Outcomes. 2006 Sep 27;4:71. doi: 10.1186/1477-7525-4-71. Health Qual Life Outcomes. 2006. PMID: 17005043 Free PMC article. Clinical Trial.

Cite

Share

4

Cite

Share

Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.

Revicki DA, Willian MK, Menter A, Gordon KB, Kimball AB, Leonardi CL, Langley RG, Kimel M, Okun M. Revicki DA, et al. Among authors: willian mk. J Dermatolog Treat. 2007;18(6):341-50. doi: 10.1080/09546630701646172. J Dermatolog Treat. 2007. PMID: 18058494 Clinical Trial.

Cite

Share

5

Cite

Share

Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.

Yarlas A, D'Haens G, Willian MK, Teynor M. Yarlas A, et al. Among authors: willian mk. Inflamm Bowel Dis. 2018 Jan 18;24(2):450-463. doi: 10.1093/ibd/izx041. Inflamm Bowel Dis. 2018. PMID: 29361097 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.

Shikiar R, Heffernan M, Langley RG, Willian MK, Okun MM, Revicki DA. Shikiar R, et al. Among authors: willian mk. J Dermatolog Treat. 2007;18(1):25-31. doi: 10.1080/09546630601121060. J Dermatolog Treat. 2007. PMID: 17365264 Clinical Trial.

Cite

Share

7

Cite

Share

Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.

Revicki DA, Willian MK, Menter A, Saurat JH, Harnam N, Kaul M. Revicki DA, et al. Among authors: willian mk. Dermatology. 2008;216(3):260-70. doi: 10.1159/000113150. Epub 2008 Jan 11. Dermatology. 2008. PMID: 18187944 Clinical Trial.

Cite

Share

8

Cite

Share

Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population.

Wu EQ, Feldman SR, Chen L, Kaltenboeck A, Yu AP, Gupta SR, Laitinen D, Willian MK. Wu EQ, et al. Among authors: willian mk. Curr Med Res Opin. 2008 Dec;24(12):3493-501. doi: 10.1185/03007990802551057. Curr Med Res Opin. 2008. PMID: 19032131

Cite

Share

9

Cite

Share

Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States.

Anis AH, Bansback N, Sizto S, Gupta SR, Willian MK, Feldman SR. Anis AH, et al. Among authors: willian mk. J Dermatolog Treat. 2011 Apr;22(2):65-74. doi: 10.3109/09546630903551258. Epub 2010 May 5. J Dermatolog Treat. 2011. PMID: 20443663

Cite

Share

10

Cite

Share

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.

Revicki D, Willian MK, Saurat JH, Papp KA, Ortonne JP, Sexton C, Camez A. Revicki D, et al. Among authors: willian mk. Br J Dermatol. 2008 Mar;158(3):549-57. doi: 10.1111/j.1365-2133.2007.08236.x. Epub 2007 Nov 28. Br J Dermatol. 2008. PMID: 18047521 Clinical Trial.

Cite

Share